CDD-1274
CDD-1274 is an inhibitor of the ERα (estrogen receptor α) variant. It facilitates the proteasomal degradation of ERα variants in breast cancer cell lines, leading to the degradation of Y537SERα. CDD-1274 effectively blocks both ligand-dependent and ligand-independent ER signaling pathways in endocrine-resistant breast cancer cells. It is used in breast cancer research.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog